Reduced Exosomal miR-22 Promotes Cisplatin Resistance and Migration in Non-Small Cell Lung Cancer Cells Through MDM4 Upregulation
OncoTargets and Therapy · 2026-09 · Volume 19 · 1-18
DOI: 10.2147/ott.s609640 ↗Kurz gefasst
Fachartikel in der Zeitschrift OncoTargets and Therapy, 2026-09. Verfasst von Peng Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Inner Mongolia People's Hospital, Hohhot, Inner Mongolia Autonomous Region, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Inner Mongolia People's Hospital, Hohhot, Inner Mongolia Autonomous Region, People's Republic of China.
ORCID-Profile: Rigetu Zhao
Zitieren
APA
Wang, P., Jiao, J., Yu, L., & Zhao, R. (2026). Reduced Exosomal miR-22 Promotes Cisplatin Resistance and Migration in Non-Small Cell Lung Cancer Cells Through MDM4 Upregulation. OncoTargets and Therapy, Volume 19, 1-18. https://doi.org/10.2147/ott.s609640
Vancouver
Wang P, Jiao J, Yu L, Zhao R. Reduced Exosomal miR-22 Promotes Cisplatin Resistance and Migration in Non-Small Cell Lung Cancer Cells Through MDM4 Upregulation. OncoTargets and Therapy. 2026;Volume 19:1-18. doi:10.2147/ott.s609640
BibTeX
@article{Wang2026,
author = {Wang, Peng and Jiao, Jie and Yu, Lijun and Zhao, Rigetu},
title = {Reduced Exosomal miR-22 Promotes Cisplatin Resistance and Migration in Non-Small Cell Lung Cancer Cells Through MDM4 Upregulation},
journal = {OncoTargets and Therapy},
year = {2026},
volume = {Volume 19},
pages = {1--18},
doi = {10.2147/ott.s609640}
}
EUVIMED